NCT00247364已完成2 期
A Double Blind Crossover Trial of Levetiracetam (Keppra®) and Placebo in the Treatment of Restless Legs Syndrome (RLS)
Sleep Health Centers2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2003年11月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
- 试验地点
- 2
- 主要终点
- 1:To investigate the efficacy of levetiracetam when used to treat RLS.
研究概览
简要总结
To define the effective dose and tolerability of levetiracetam in individuals with Restless Legs Syndrome (RLS). It is hypothesized that levetiracetam will be well tolerated, safe and effective in treating the symptoms of RLS.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 85 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosed with idiopathic RLS according to the four IRLSSG diagnostic criteria
- •An urge to move the legs, usually accompanied or caused by uncomfortable and unpleasant sensations in the legs.
- •The urge to move or unpleasant sensations begin or worsen during periods of rest or inactivity such as sitting or lying down.
- •The urge to move or unpleasant sensations are partially or totally relieved by movement, such as walking or stretching, at least as long as the activity continues
- •The urge to move or unpleasant sensations are worse in the evening or night than during the day or only occur in the evening or night.
- •IRLS Rating Scale score greater than 15 at Baseline visit PLM-Index of 5 or greater during the first night of polysomnography Written informed consent obtained prior to any study procedures being performed.
排除标准
- •Women of childbearing potential, who have a positive urine pregnancy test or are lactating as the screening visit, or do not practice a clinically accepted method of contraception.
- •Individuals who are taking medication for Restless Legs Syndrome without a proper washout period
- •Individuals who are taking hypnotics, sedatives, antipsychotics, or neuroleptics
- •History of current diagnosis of other clinically relevant diseases that may confound assessments of RLS symptoms (e.g., Parkinson's disease, dementia, ALS, etc.)
- •Subjects with serum ferritin below 10µg/L
- •Subjects with an untreated sleep disorder that may confound assessments (e.g., narcolepsy, sleep apnea syndrome or other breathing-related sleep disorders, or REM sleep behaviour disorder)
- •Subjects with an apnea/hypopnea index of 15 or greater at the initial polysomnography visit
- •Subjects employed in shift work (e.g., employment hours disruptive to the normal circadian sleep-wake cycle such as nighttime or variable rotating shifts)
- •Subjects who have clinically significant or unstable medical conditions which in the opinion of the investigator would render the subject unsuitable for the study (e.g. severe cardiovascular disease, major depression, psychosis, hepatic or renal failure, etc.)
- •subjects with a positive urine drug test for illicit use of amphetamines, barbiturates, benzodiazepines, opiates, synthetic narcotics, and miscellaneous drugs commonly known as recreational drugs (e.g., cannabinoids including THC, heroine, cocaine)
- •Participation in any clinical drug or device trial in the 30 days prior to the screening visit.
结局指标
主要结局
1:To investigate the efficacy of levetiracetam when used to treat RLS.
2:To assess tolerability and adverse event rates.
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
3 期
A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures (Except Partial Seizures Evolving to Secondarily Generalized Seizures)Generalized Tonic-Clonic SeizuresEpilepsyNCT01228747UCB Japan Co. Ltd.361
已完成
2 期
A 16 Week Study Evaluating Levetiracetam in the Treatment of Post Herpetic Neuralgia (PHN)Neuralgia, PostherpeticNCT00160511UCB Pharma170
尚未招募
不适用
Phenobarbitone vs Levetiracetam in term asphyxiated babies.CTRI/2020/05/025416Department of Neonatology
已完成
3 期
Efficacy and Safety of Levetiracetam in Partial Seizures Control, With or Without Secondary GeneralizationPartial SeizuresEpilepsyNCT01392768Ache Laboratorios Farmaceuticos S.A.126
已完成
不适用
Levetiracetam for Treatment of Pain Associated With FibromyalgiaFibromyalgiaNCT00254657University of California, San Francisco66